Sign inGet started

Gault Cheryl

Insider CIK 1839046 · CYCN Chief Operating Officer · RAPP Chief Operations Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RAPP Rapport Therapeutics, Inc. S Sale2026-09-302026-10-012,075$33.76 $70.0K139,914SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-09-302026-10-017,925$33.04 $261.8K141,989SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-06-302026-07-013,792$41.39 $157.0K154,222SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-06-302026-07-011,900$40.09 $76.2K158,014SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-06-302026-07-013,308$42.17 $139.5K150,914SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-06-302026-07-011,000$43.15 $43.1K149,914SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-03-302026-03-312,839$28.55 $81.1K159,914SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-03-302026-03-317,161$28.04 $200.8K162,753SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2026-03-052026-03-092,014$28.93 $58.3K169,914SEC↗
RAPP Rapport Therapeutics, Inc. A Award deriv2026-02-022026-02-04132,000— $0132,000SEC↗
RAPP Rapport Therapeutics, Inc. M Exercise deriv2025-11-262025-12-015,000— $0105,407SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2025-11-262025-12-015,000$30.10 $150.5K171,928SEC↗
RAPP Rapport Therapeutics, Inc. M Exercise2025-11-262025-12-015,000$1.80 $9.0K176,928SEC↗
RAPP Rapport Therapeutics, Inc. M Exercise deriv2025-09-082025-09-105,000— $0110,407SEC↗
RAPP Rapport Therapeutics, Inc. S Sale2025-09-082025-09-105,000$38.33 $191.7K171,928SEC↗
RAPP Rapport Therapeutics, Inc. M Exercise2025-09-082025-09-105,000$1.80 $9.0K176,928SEC↗
RAPP Rapport Therapeutics, Inc. A Award2025-03-032025-03-0513,987— $0171,928SEC↗
RAPP Rapport Therapeutics, Inc. A Award deriv2025-02-032025-02-04129,000— $0129,000SEC↗
RAPP Rapport Therapeutics, Inc. A Award deriv2024-06-062024-06-1088,442— $088,442SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2022-01-202022-01-24135,000— $0135,000SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2021-12-092021-12-10100,000— $0100,000SEC↗